Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
P
2801
PUT
Everpure Inc
P
$37B
| $2.35M | ﹤0.01% |
+35,000
| New | +$2.92M |
|
|
BORR
2802
Borr Drilling
BORR
$1.25B
| $2.34M | ﹤0.01% |
581,815
+68,007
| +13% | +$225K |
|
2803
iShares MSCI USA Momentum Factor ETF
MTUM
$26.1B
| $2.34M | ﹤0.01% |
9,355
+2,107
| +29% | +$529K |
|
2804
Nelnet
NNI
$4.52B
| $2.34M | ﹤0.01% |
17,611
-967
| -5% | -$127K |
|
|
PLYM
2805
DELISTED
Plymouth Industrial REIT
PLYM
| $2.33M | ﹤0.01% |
106,527
-30,204
| -22% | -$664K |
|
2806
DXP Enterprises
DXPE
$3.04B
| $2.33M | ﹤0.01% |
21,229
+1,638
| +8% | +$178K |
|
2807
Allegro MicroSystems
ALGM
$7.92B
| $2.33M | ﹤0.01% |
88,300
-62,725
| -42% | -$1.73M |
|
2808
Peoples Bancorp
PEBO
$1.48B
| $2.32M | ﹤0.01% |
77,400
+16,710
| +28% | +$496K |
|
2809
CALL
Telephone and Data Systems
TDS
$3.82B
| $2.32M | ﹤0.01% |
56,600
-40,500
| -42% | -$1.58M |
|
2810
Asana
ASAN
$2.07B
| $2.32M | ﹤0.01% |
169,031
-342,029
| -67% | -$4.7M |
|
2811
Bar Harbor Bankshares
BHB
$677M
| $2.32M | ﹤0.01% |
74,632
+21,864
| +41% | +$665K |
|
2812
CALL
XPO
XPO
$24.7B
| $2.31M | ﹤0.01% |
17,000
| – | – |
|
2813
Ziff Davis
ZD
$1.92B
| $2.31M | ﹤0.01% |
65,697
+5,889
| +10% | +$205K |
|
2814
IPG Photonics
IPGP
$3.71B
| $2.3M | ﹤0.01% |
32,149
-1,293
| -4% | -$106K |
|
|
THR
2815
DELISTED
Thermon Group Holdings
THR
| $2.3M | ﹤0.01% |
61,848
+4,777
| +8% | +$157K |
|
|
USAR
2816
USA Rare Earth Inc
USAR
$4.51B
| $2.3M | ﹤0.01% |
192,889
+189,619
| +5,799% | +$3.61M |
|
2817
CALL
CME Group
CME
$94.3B
| $2.29M | ﹤0.01% |
8,400
+5,600
| +200% | +$1.52M |
|
2818
MarketWise
MKTW
$55.5M
| $2.29M | ﹤0.01% |
152,631
+9,961
| +7% | +$156K |
|
2819
Flowers Foods
FLO
$1.52B
| $2.29M | ﹤0.01% |
210,608
-199,163
| -49% | -$2.31M |
|
2820
ARS Pharmaceuticals
SPRY
$601M
| $2.29M | ﹤0.01% |
196,387
-32,182
| -14% | -$313K |
|
|
DRD
2821
DRDGold
DRD
$2.1B
| $2.29M | ﹤0.01% |
73,738
-32,441
| -31% | -$927K |
|
2822
Wolverine World Wide
WWW
$1.63B
| $2.28M | ﹤0.01% |
125,731
+10,178
| +9% | +$206K |
|
2823
PUT
JetBlue
JBLU
$2.18B
| $2.27M | ﹤0.01% |
500,000
| – | – |
|
2824
PAR Technology
PAR
$741M
| $2.27M | ﹤0.01% |
62,540
+3,859
| +7% | +$139K |
|
2825
Axogen
AXGN
$2.67B
| $2.27M | ﹤0.01% |
69,303
+4,440
| +7% | +$109K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.